Raymond J H Westheim is a notable inventor based in Oss, Netherlands. He has made significant contributions to the pharmaceutical industry, particularly in the formulation of innovative drug compounds. With a total of 5 patents to his name, Westheim's work has had a considerable impact on the development of effective medications.

Latest Patents

One of Westheim's latest patents is for pharmaceutical tablets of crystalline type II aripiprazole. This formulation is designed to have a reduced dissolution profile variability upon storage, enhancing the stability and effectiveness of the medication. Another significant patent involves hydrates of erlotinib hydrochloride, which are formed from an aqueous solution. This compound is useful both as a pharmaceutical and as a purification intermediate, showcasing Westheim's innovative approach to drug development.

Career Highlights

Westheim is currently associated with Synthon B.V., a company known for its focus on developing complex generics and innovative medicines. His work at Synthon has allowed him to collaborate with other talented professionals in the field, further advancing pharmaceutical research and development.

Collaborations

Some of Westheim's notable coworkers include Gerrit J B Ettema and Faysal Kalmoua. Their collaborative efforts contribute to the innovative environment at Synthon, fostering advancements in pharmaceutical technology.

Conclusion

Raymond J H Westheim's contributions to the pharmaceutical industry through his patents and collaborations highlight his role as a key innovator. His work continues to influence the development of effective medications, making a lasting impact on healthcare.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com